Bristol Myers Squibb (BMY) Exchange Rate Effect (2009 - 2026)

Bristol Myers Squibb has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$48.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 172.73% year-over-year to -$48.0 million; the TTM figure through Mar 2026 stood at $81.0 million (up 411.54% YoY), while the FY2025 annual figure was $195.0 million, up 242.34% from the prior year.
• Exchange Rate Effect declined to -$48.0 million in Q1 2026, from $5.0 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for BMY reached as high as $128.0 million in Q2 2025 and fell as low as -$147.0 million in Q4 2024.
• The 5-year median for Exchange Rate Effect is -$4.0 million (2025), against an average of $1.3 million.
• Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 494.44% — and 2025, when it jumped 681.82%.
• A 5-year view of Exchange Rate Effect shows it stood at $95.0 million in 2022, then dropped by 17.89% to $78.0 million in 2023, then tumbled by 288.46% to -$147.0 million in 2024, then soared by 103.4% to $5.0 million in 2025, then tumbled by 1060.0% to -$48.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$48.0 million, $5.0 million, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.